qz
Roche is striking a $2.3 billion deal with Nurix Therapeutics to develop a blood cancer drug

Nurix receives $700 million upfront to co-develop bexobrutideg, an oral BTK degrader targeting chronic lymphocytic leukemia and other diseases [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Match Score: 115.38

Destination
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 85.8% in Nurix Therapeutics (NRIX). While the effectiveness of this hig [...]

Match Score: 79.68

Destination
Roche says it will invest $50 billion in the U.S. as tariff fears hit pharma

With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will invest $50 billion in the United States over the next five years, expanding it [...]

Match Score: 68.57

Destination
Facebook scammers want you to think Elon Musk can cure diabetes

Elon Musk discovered a simple 30-second “fridge trick” that can reverse diabetes, but the discovery has spooked pharmaceutical companies so much they put a $78 million bounty on his head, forcing [...]

Match Score: 53.00

Destination
Masimo files lawsuit over Apple's 'redesigned' blood oxygen monitoring feature

Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released i [...]

Match Score: 52.26

Destination
How to turn on hypertension alerts on Apple Watch

Apple has steadily expanded the Apple Watch’s health monitoring features over the years, moving beyond fitness tracking into areas that can offer early insight into potential medical concerns. One o [...]

Match Score: 52.26

Destination
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan S [...]

Match Score: 49.59

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 48.53

qz
Eli Lilly is acquiring blood cancer drug developer Ajax Therapeutics for up to $2.3 billion

The deal centers on AJ1-11095, a first-in-class experimental oral drug in early-stage trials for myelofibrosis patients [...]

Match Score: 47.03